97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2012-002023-15-AT
(EUCTR)
21/09/201204/09/2012Mesacol: The effect of mesalazine on molecular pathways ofcell adhesion in ulcerative colitisMesacol: The effect of mesalazine on molecular pathways ofcell adhesion in ulcerative colitis - Mesacol Ulcerative colitis
MedDRA version: 14.1;Level: LLT;Classification code 10045366;Term: Ulcerative colitis, unspecified;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Trade Name: Mezavant 1200 mg magensaftresistente Retardtabletten
INN or Proposed INN: MESALAZINE
Other descriptive name: 5-aminosalicylic acid
Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und HepatologieNULLNot RecruitingFemale: yes
Male: yes
12Phase 2Austria